Showing results (161-170 of 1,748) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2002
The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cellsStefan W Krause, Christine Neumann, Afasaneh Soruri, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 7, 2001
Cytokines and immune response in the tumor microenvironmentS Mocellin, E Wang, F M MarincolaJournal of Immunotherapy (Hagerstown, Md. : 1997)|November 7, 2001
Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific T-cell responseC L Nguyen, J T Bui, M Demcheva, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 21, 2002
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological TherapyUlrich Keilholz, Jeffrey Weber, James H Finke, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2002
Interleukin-18 and host defense against infectious pathogensKazuyoshi KawakamiJournal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2002
Serum interleukin-18 concentrations in patients with inflammatory bowel diseaseDaisuke Furuya, Atsuhito Yagihashi, Momoko Komatsu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
Do CD4+ CD25+ immunoregulatory T cells hinder tumor immunotherapy?Paul Andrew Antony, Nicholas P RestifoJournal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
Murine dendritic cell-induced tumor apoptosis is partially mediated by nitric oxideHiromune Shimamura, Rachel Cumberland, Kazumasa Hiroishi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
A gene encoding human gastric signet ring cell carcinoma antigen recognized by HLA-A31-restricted cytotoxic T lymphocytesHiroeki Sahara, Yuki Nabeta, Toshihiko Torigoe, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanomaMark E Dudley, John R Wunderlich, James C Yang, et al.Pageof 175